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Purpose:  This study  aimed  to evaluate  the  macroscopic  and  microscopic  peritoneal  ﬁndings
after intraperitoneal  injection  of  alcohol  in rats.
Methods: From  January  to  February  2012,  20 male  rats  were  used  in this  study:  15 rats
received  intraperitoneal  injection  of  0.1  mL  99.9%  alcohol  (group  1: experiment  group)  and
5 rats  received  intraperitoneal  injection  of  0.1 mL  normal  saline  (group  2: control  group).
Animals from  each  group  were  sacriﬁced  the  day  after  alcohol  injection  and  each  week
thereafter.  Macroscopic  and  microscopic  examinations  of the  peritonea  and  abdominal
cavity  were  performed  in  each  rat.
Results: There  was  no signiﬁcant  peritoneal  abnormality  on  macroscopic  view,  except  for  a
whitish-colored  parietal  peritoneum  around  the injection  site  in 3 animals  from  group  1.
In all  but  1 of  the  animals  in group  1, mild  to  moderate  peritoneal  inﬂammation  or ﬁbrosis
was  observed  1 and  2 weeks  after  alcohol  injection.  However,  the  peritoneal  abnormality
of  alcohol  injection  had  dissipated  by week  3.  Peritoneal  abnormalities  were  not  observed
in group  2.
Conclusion:  An  intraperitoneal  injection  of alcohol  in rats  caused  peritoneal  inﬂammation  or
ﬁbrosis during  the  ﬁrst 2 weeks.  However,  these  peritoneal  abnormalities  were  short-lived
and  had  completely  disappeared  after  3 weeks.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. Introduction
Alcohol (i.e., ethanol) is a widely used sclerosing agent
n  clinical practice because of its effectiveness, ease of use,
ong  shelf-life, and low cost [1–6]. Alcohol sclerotherapy is
he  ﬁrst-choice treatment for benign cystic lesions of vari-
us  organs and has been used to treat benign solid thyroid
odules or venous malformations [2–6]. A concentration of
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95–100% is most commonly used because it rapidly coag-
ulates  the cells lining the cyst [7]. However, because of the
coagulative power of alcohol, concerns have been raised
about  potential complications from alcohol leakage during
or  after the procedure.
The  experimental assessment of intraperitoneal ethanol
leakage may  be helpful to the doctors who perform alco-
hol  sclerotherapy for benign intraabdominal lesions by
predicting potential complications. To the best of our
knowledge, no animal study regarding the histopathology
or related ﬁndings following intraperitoneal injection of
alcohol  was found. The purpose of this study was to eval-
uate  the macroscopic and microscopic ﬁndings following
intraperitoneal injection of alcohol in rats, as well as the
related  ﬁndings.
 access article under the CC BY-NC-ND license
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2. Materials and methods
All  experiments were approved by our Institutional Ani-
mal  Review Board and were conducted in accordance with
the  Korean Physiological Society’s Guiding Principles on the
Care  and Use of Animals. From January to February 2012,
this  study employed 20 male Sprague-Dawley rats (Sam-
taco,  Osan, South Korea), each weighing approximately
200 g (7 weeks old). All rats were maintained in an air-
conditioned area, and were regularly provided with water
and  laboratory chow ad libitum. The dosage of alcohol was
determined on the basis of the recommendation to keep
alcohol doses below 1 mL  alcohol/kg in humans [8]: the
maximum dose of alcohol for a rat weighing 200 g can be
calculated as 0.2 mL,  and a half of the maximum dose of
alcohol  was used in this study.
The rats were divided into 2 groups: 15 animals were
injected intraperitoneally with 0.1 mL  of 99.9% alcohol
(Merck, Darmstadt, Germany) and were classiﬁed as the
experiment group (group 1). The remaining 5 rats were
injected intraperitoneally with 0.1 mL  of normal saline and
were  classiﬁed as the control group (group 2). The dosage
of  alcohol was 0.1 mL  in each rat, and was arbitrarily deter-
mined  by considering the fact that the maximum amount
of  alcohol per sclerotherapy session in humans is 1 mL
alcohol/kg of body weight. An alcohol concentrations of
99.9%  was selected based on prior reports of alcohol scle-
rotherapy in peritoneal cysts [3]. The dosage of alcohol and
normal  saline was the same.
Injection of alcohol and normal saline was carried out
by  an experienced member of the research team. Each
rat  was anesthetized with a 5% enﬂurane–oxygen mixture
(1  L/min). The animal’s respiratory patterns and extremity
color were closely monitored. Prior to injection, each rat
Table 1
Macroscopic ﬁndings and microscopic results of the abdomen after injection of a
Group Day sacriﬁced Macroscopic ﬁnding 
1 1st  Normal 
1st  Normal 
1st  Normal 
7th  Whitish change of parietal peritoneum,
Visible injection site
7th  Whitish change of parietal peritoneum,
Visible injection site
7th  Normal 
14th Normal 
14th Normal 
14th Whitish change of parietal peritoneum 
21th Normal 
21th Normal 
21th Normal 
28th Normal 
28th Normal 
28th Normal 
2 1st  Normal 
7th Normal 
14th Normal 
21th Normal 
28th Normal orts 1 (2014) 31–35
was  placed in a supine position and the skin was scrubbed
with povidone-iodine (polyvinylpyrrolidone iodine). A 23-
gauge  needle attached to a 1 mL  syringe was  inserted on
the  upper side of the navel and 0.1 mL  alcohol was  injected
into  the peritoneal cavity. For the accurate intraperitoneal
injection of alcohol, the beveled portion of the needle tip
was  removed by repeatedly folding it using the forcep, and
the  position of the needle in the intraperitoneal cavity was
conﬁrmed  prior to injection of alcohol by administering
1 mL  room air. Following alcohol injection, the puncture
site was  marked by Gentian violet to identify injection site
on  the sacriﬁcial day. The entire procedure was  performed
under general anesthesia in each rat.
On the day after alcohol injection, 3 rats in group 1 and 1
rat  in group 2 were sacriﬁced and abdominal cavity in each
rat  was  macroscopically examined by the same investiga-
tor,  and then he collected tissue samples for microscopic
examination. This was repeated each week until 4 weeks
after  alcohol injection. The macroscopic appearance of the
abdominal  cavity was  subsequently evaluated in all 20 rats
and  microscopic analyses were performed on tissue sam-
ples  obtained from 3 sites: (1) the parietal peritoneum,
including the injection site and a further site remote from
the  site of injection; (2) the visceral peritoneum, includ-
ing  the small bowel with mesentery and large bowel with
mesocolon; and (3) a free-margined portion of liver. All
specimens were ﬁxed in 10% neutralized formalin and
processed with parafﬁn-embedding. After making parafﬁn-
blocks,  specimens were sectioned by 5 m thickness by
microtome and stained with hematoxylin and eosin stain.
There  is no standardized grading system for inﬂammation
in histology, but the evaluation of inﬂammation of peri-
toneum and liver was  performed by single pathologist as
follows:  none; no inﬁltration of inﬂammatory cell, mild; a
lcohol (group 1) and normal saline (group 2) in rats.
Microscopic ﬁnding of the peritonea
Parietal Visceral
Moderate inﬂammation Mild inﬂammation
Mild inﬂammation Mild inﬂammation
Mild inﬂammation Mild inﬂammation
Mild inﬂammation
Fibrosis
Mild  inﬂammation
Mild inﬂammation
Fibrosis
Foreign body reaction
Moderate inﬂammation
Foreign  body reaction
Normal Normal
Mild inﬂammation
Foreign body reaction
Mild inﬂammation
Mild inﬂammation Normal
Mild inﬂammation Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
Normal Normal
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ew inﬂammatory cells including lymphocytes or plasma
ells  (less than 10/HPF [400×]), moderate; some dozens of
ymphocytes or plasma cells inﬁltrates in 1HPF (400×), and
evere;  intense inﬁltration of inﬂammatory cells.
.  Results
Of the 20 rats, no infection or other complications
n the abdominal wall around injection site were found.
acroscopic and microscopic ﬁndings after intraperitoneal
njection of alcohol in rats are summarized in Table 1. In
roup  1, the abdomen of all 3 rats sacriﬁced 1 day after alco-
ol  injection showed no color change of the peritoneum or
ther  macroscopic abnormality, but they microscopically
evealed mild to moderate inﬂammation of the parietal or
isceral  peritoneum (Fig. 1). And, 2 animals from group
 displayed a patchy or round shaped, lighter-colored
arietal peritoneum around the injection site on macro-
copic view, 1 week after alcohol injection. This ﬁnding
as present in only 1 animal by 2 weeks post-injection.
hese animals also had mild peritoneal inﬂammation, and
ig. 1. Microscopic ﬁndings of the peritoneum in a rat sacriﬁced 1 day
fter intraperitoneal alcohol injection. Moderate inﬂammation with neu-
rophils (arrow) is observed in the parietal peritoneum (H&E, 200× (A)
nd 400× (B)).
Fig. 2. Microscopic ﬁndings of the peritoneum in a rat sacriﬁced 1 week
after intraperitoneal alcohol injection. Mild to moderate inﬂammation is
observed in addition to ﬁbrotic change (black arrow) and foreign body
reaction (open arrow) in both the parietal (A) and visceral (B) peritonea.
Foreign body reaction, comprising histiocytes and foreign body-type
multinucleated giant cells (black arrowhead) with foreign material (open
arrowhead), is noted in the epimysium (H&E, 100×).
ﬁbrosis or foreign body reaction on microscopic inspection,
which was  more pronounced in 1 week than in 2 week
post-injection (Fig. 2).
By  3 and 4 weeks, all animals in group 1 had a normal
peritoneal anatomy on both macroscopic and microscopic
examinations. All animals in group 2 showed a normal
peritoneum on both macroscopic and microscopic exami-
nations  at all time-points examined. Hepatic abnormalities
or ascites were not observed on macroscopic or micro-
scopic examination in any of the animals from either group,
at  any time-point examined in this study.
4. DiscussionAlcohol is a widely used sclerosant in the treatment of
benign  cystic lesions in humans. Alcohol has the advan-
tages of being inexpensive, efﬁcacious, and easy to use
[2–6,9].  Alcohol concentrations ranging from 95% to 100%
logy Rep
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have been used because, at these concentrations, alcohol
rapidly (1–3 min) coagulates the cells lining the cyst [7].
Sufﬁcient amount of alcohol, which can replace 10–90% of
the  aspirated ﬂuid in the cystic lesions, and multiple alco-
hol  injections for large cystic lesions (>400 mL in volume)
have  been proposed [10,11]. In general, it is recommended
that the amount of alcohol injected should not exceed 1 mL
alcohol/kg  of body weight, and that a single dose should not
exceed  20 mL  [8,10,11].
Alcohol exerts its therapeutic effect by inducing an
intense inﬂammatory reaction when it comes into contact
with  the epithelial lining of benign cysts, or transected lym-
phatic  vessels. The cells lining the cyst cavity are ﬁxed,
thereby disabling their ability to secrete ﬂuid and pro-
mote cyst enlargement [1]. In tissues, ethanol induces
cellular dehydration and protein denaturation, followed
by  coagulation necrosis, small vessel thrombosis, hemor-
rhagic  infarction, and reactive ﬁbrosis [5].
Alcohol leakage can result in necrosis of the surrounding
tissue. Several reports indicate that alcohol sclerotherapy
can cause major complications, including skin necrosis,
peripheral nerve palsies, and hypotensive crisis, as well
as  fatalities from cardiac arrest and pulmonary emboli
[8,12–16]. These complications are closely related to
intravascular injection of alcohol for sclerotherapy of vas-
cular  malformation, and absolute alcohol can be used as
a  thromboembolic agent by direct intravascular injection
[8,14–16]. A greater hemodynamic changes can arise from
a  single bolus injection of absolute alcohol rather than as
a  result of the total amount of absolute alcohol used dur-
ing  alcohol embolotherapy of arteriovenous malformations
of  the extremities [17]. One study has demonstrated that
alcohol  can cause a sclerosing cholangitis-like abnormality
in  the bile ducts or signiﬁcant neurotoxicity [7]. However,
these complications may  be attributed to procedural errors,
such  as incorrect positioning of the needle or catheter
drainage [12–14]. Therefore, alcohol leakage is a serious
concern particularly in cases of alcohol sclerotherapy for
intraabdominal or retroperitoneal cystic lesions.
To the best of our knowledge, only 1 study has exam-
ined experimental intraperitoneal injection of alcohol [18].
This  study showed intraabdominal complications related
to  peritoneal leakage of signiﬁcant amounts of alcohol in
rats.  However, the study focused on the peritoneal ﬁnding
of  picibanil by using intraperitoneal alcohol injection in a
limited  number of rats as control group [18]. They injected a
0.5  mL  alcohol, which caused various degrees of peritoneal
adhesion and inﬂammation. In contrast, we used 0.1 mL
alcohol  in an attempt to reduce the likelihood of severe
peritoneal inﬂammation or intraabdominal complications,
which we suggest is proportional to the amount of alcohol
injected. Considering the recommendation to keep alcohol
doses  below 1 mL  alcohol/kg in humans [8], the maximum
dose of alcohol for a rat weighing 200 g can be calculated as
0.2  mL.  The results of the present study show that 0.1 mL
intraperitoneal injection of alcohol caused mild to mod-
erate  peritoneal inﬂammation and ﬁbrosis in rats up to
2  weeks post-injection. Thereafter, the adverse effects of
alcohol  therapy slowly resolved and were no longer evident
by  3 week post-injection. The reason for the complete res-
olution  of peritoneal inﬂammation or ﬁbrosis is not clear,
[orts 1 (2014) 31–35
but  may  be related to the hypothesis that a scattering
alcohol in the injection happened because of a blunting of
the  needle caliber in cutting the needle tip when the alcohol
becomes inert after rapid dilution with blood ﬂow or ﬂuid.
Patchy  or round-shaped, peritoneal discoloration around
injection site supports this hypothesis. However, we  can-
not  explain the exact cause of foreign body reaction, but it
may  be the unexpected intraperitoneal ingression of dust
particles  attached to rat’s hairs because of no shaving.
This study has several limitations. The major limitation
is the use of single dose of alcohol, and thus, comparison
study using varying alcohol dose may  be required. Second,
this  study focused on peritoneal ﬁndings occurring after
alcohol  injection. We  did not assess the histopathology of
all  intraabdominal organs, or other systemic ﬁndings, such
as  fever or heart rate. Third, blood count analysis and other
laboratory evaluations were not performed. Finally, long-
term  follow-up over 1 month was  not conducted.
In conclusion, an intraperitoneal alcohol injection in rats
promoted short-term peritoneal inﬂammation or ﬁbrosis,
which  resolved 3 weeks post-injection.
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